Indications and uses
Helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
Badger Damascus Rose Broad Spectrum SPF 20 Face Sunscreen
- Manufacturer
- W.S. Badger Company, Inc. | Norwood Packaging Ltd.
- Effective date
- 2014-06-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:35:35
Label at a glance#
ProductBadger Damascus Rose Broad Spectrum SPF 20 Face Sunscreen
Active ingredientZINC OXIDE
Label structure8 sections
Dosage and administration
For full protection, apply liberally to face and neck 15 minutes before sun exposure. Use a water resistant sunscreen if swimming or sweating Reapply: At least every 2 hours Spending time in the sun increases your risk of skin cancer and early skin aging To decrease this risk, regularly use a sunscreen with Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun,...
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredient
Non-Nano Uncoated Zinc Oxide 12.0%
Purpose
Sunscreen
Uses
- Helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings
For external use only.
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin. Stop use and ask a doctor if rash occurs.
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.
Directions
- For full protection, apply liberally to face and neck 15 minutes before sun exposure.
- Use a water resistant sunscreen if swimming or sweating
Reapply:
- At least every 2 hours
Sun Protection Measures:
- Spending time in the sun increases your risk of skin cancer and early skin aging
- To decrease this risk, regularly use a sunscreen with Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10am-2pm
- Wear long-sleeved shirts, pants, hats, and sunglasses
- For children under 6 months of age: ask a doctor.
Ingredients
1Aloe Barbadensis (Aloe) Leaf Juice, 1Helianthus Annuus (Sunflower) Seed Oil, Carthamus Tinctorious (Safflower) Oleosomes,1Sucrose Cocoate (from Coconut), 1Alcohol Denat. (38B Lavender), Leuconostoc Ferment Filtrate (from Radish), Microstalline Cellulose (and) Algin, Citric Acid, Phenethyl Alcohol, 1Glycerin (from Soybean), 1Lavandula Angustifolia (Lavender) Flower Oil, 1Hippophae Rhamnoides (Seabuckthorn) Fruit Extract,1Rosa Canina (Rosehip) Fruit Extract, 1Rosa Damascena (Rose) Flower Oil, 1Anthemis Nobilis (Chamomile) Flower Oil, 1Calendula Officinalis (Calendula) Flower Extract, Xanthan Gum, Sodium Phytate, Sodium Gluconate, 1Lecithin (from Soybean), Tocopherol (Sunflower Vitamin E).
1 = Certified Organic
PRINCIPAL DISPLAY PANEL - 47 ml Tube Carton
BADGER®
Damascus rose
with Lavender & Chamomile
BROAD SPECTRUM
SPF 20
ANTI-AGING
FACE SUNSCREEN
Protect & Restore
UVA
UVB
NON
NANO
NON
COMEDO-
GENIC
HYPO-
ALLERGENIC
100% CERTIFIED NATURAL
CONTAINS ORGANIC
INGREDIENTS
• NATURAL PRODUCTS ASSOCIATION •
CERTIFIED
NSF
contains organic
ingredients
47 ml/1.6 fl.oz
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62206-4901-8 | 2021-09-27 | C162847 | 48780-1 | 9855e2a2-45b1-60a7-e053-dbdaa90a05bd | Badger ® Damascus Rose Broad Spectrum SPF 20 Face Sunscreen |
| 62206-4901-8 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-45b1-60a7-e053-dbdaa90a05bd | Badger ® Damascus Rose Broad Spectrum SPF 20 Face Sunscreen |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 1 | |
| CALENDULA OFFICINALIS FLOWER | INACTIVE INGREDIENT | P0M7O4Y7YD | 1 | |
| CARTHAMUS TINCTORIUS SEED OLEOSOMES | INACTIVE INGREDIENT | 9S60Q72309 | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CHAMAEMELUM NOBILE FLOWER OIL | INACTIVE INGREDIENT | UB27587839 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HIPPOPHAE RHAMNOIDES FRUIT | INACTIVE INGREDIENT | AVL0R9111T | 1 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE | INACTIVE INGREDIENT | D2QHA03458 | 1 | |
| PHENYLETHYL ALCOHOL | INACTIVE INGREDIENT | ML9LGA7468 | 1 | |
| PHYTATE SODIUM | INACTIVE INGREDIENT | 88496G1ERL | 1 | |
| ROSA CANINA FRUIT | INACTIVE INGREDIENT | 3TNW8D08V3 | 1 | |
| ROSA DAMASCENA FLOWER OIL | INACTIVE INGREDIENT | 18920M3T13 | 1 | |
| SODIUM ALGINATE | INACTIVE INGREDIENT | C269C4G2ZQ | 1 | |
| SODIUM GLUCONATE | INACTIVE INGREDIENT | R6Q3791S76 | 1 | |
| SUCROSE COCOATE | INACTIVE INGREDIENT | 3H18P0UK73 | 1 | |
| SUNFLOWER OIL | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- Badger Damascus Rose Broad Spectrum SPF 20 Face Sunscreen
- ZINC OXIDE
- ALOE VERA LEAF
- SUNFLOWER OIL
- CARTHAMUS TINCTORIUS SEED OLEOSOMES
- SUCROSE COCOATE
- ALCOHOL
- LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE
- CELLULOSE, MICROCRYSTALLINE
- SODIUM ALGINATE
- ANHYDROUS CITRIC ACID
- PHENYLETHYL ALCOHOL
- GLYCERIN
- LAVENDER OIL
- HIPPOPHAE RHAMNOIDES FRUIT
- ROSA CANINA FRUIT
- ROSA DAMASCENA FLOWER OIL
- CALENDULA OFFICINALIS FLOWER
- CHAMAEMELUM NOBILE FLOWER OIL
- XANTHAN GUM
- PHYTATE SODIUM
- SODIUM GLUCONATE
- LECITHIN, SOYBEAN
- TOCOPHEROL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62206-4901 | 62206-4901-8 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, FILM COATED / ORAL | 0.08 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | 26 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER / ORAL | 275 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | INHALANT / NASAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 414 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| SODIUM ALGINATE | SODIUM ALGINATE | C269C4G2ZQ | LIQUID / TOPICAL | 0.25 %w/w | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | 62 mg | ||
| PHENYLETHYL ALCOHOL | PHENYLETHYL ALCOHOL | ML9LGA7468 | SOLUTION / OPHTHALMIC | 0.25 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | 268 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.1 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 81 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| SODIUM ALGINATE | SODIUM ALGINATE | C269C4G2ZQ | TABLET, EXTENDED RELEASE / ORAL | 627 mg | ||
| PHENYLETHYL ALCOHOL | PHENYLETHYL ALCOHOL | ML9LGA7468 | CREAM / VAGINAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | 1152 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION, CONCENTRATE / INTRAVENOUS | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CREAM / VAGINAL | 1 %w/w | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, FILM COATED / ORAL | 0.33 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | 131 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | 15 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| PHENYLETHYL ALCOHOL | PHENYLETHYL ALCOHOL | ML9LGA7468 | INHALANT / RESPIRATORY (INHALATION) | 277.1 mg | ||
| PHENYLETHYL ALCOHOL | PHENYLETHYL ALCOHOL | ML9LGA7468 | SPRAY / NASAL | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | 772 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cd03d0bb-4186-c079-e053-2995a90abad2 | 95cdf64a-41db-46de-90d3-ef913bdbd803 | 2021-09-27 | Warnings | 95cdf64a-41db-46de-90d3-ef913bdbd803 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.